Back to top
more

Zimmer Biomet Holdings, Inc. (ZBH)

(Delayed Data from NYSE)

$135.72 USD

135.72
1,596,549

+0.86 (0.64%)

Updated Aug 3, 2020 04:03 PM ET

After-Market: $135.73 +0.01 (0.01%) 4:51 PM ET

3-Hold of 5     3    

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1
2
3
4
5
S&P
Strong Buy
Buy
Hold
Sell
Strong Sell
500
24.33%
17.77%
9.37%
4.88%
1.79%
10.56%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

C Value C Growth B Momentum B VGM

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

View All Zacks #1 Ranked Stocks

Trades from $1

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Zacks News

Zacks Equity Research

Is a Surprise Coming for Zimmer Biomet (ZBH) This Earnings Season?

Zimmer Biomet (ZBH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

ZBH

Zacks Equity Research

Will Zimmer (ZBH) Beat Estimates Again in Its Next Earnings Report?

Zimmer (ZBH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

ZBH

Zacks Equity Research

Zimmer Biomet (ZBH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Zimmer (ZBH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ZBH

Zacks Equity Research

Zimmer Biomet (ZBH) to Report Q2 Earnings: What's in Store?

Zimmer Biomet's (ZBH) Hips and Knees portfolios are expected to have contributed to second-quarter top line despite pandemic-led business disruptions.

IART IDXX EXAS ZBH

Sriparna Ghosal

3 Growth-Focused MedTech Stocks to Buy Amid Coronavirus Crisis

Once the pandemic-led crisis is over, these MedTech growth-focused stocks will flourish on a number of positive developments.

DVA COO PDCO WST ZBH

Debanjana Dey

3 Affordable MedTech Growth Stocks to Buy Amid Market Unrest

Here are some MedTech stocks which might be a solid investment option amid the coronavirus-battered market conditions.

DVA MYGN ADUS ANTM ZBH

Sriparna Ghosal

3 Cheap MedTech Stocks Set to Gain Once Coronavirus Crisis Ebbs

Once the pandemic-led crisis eases, these MedTech stocks will likely flourish on the back of number of positive developments.

SYK CERN EW PDCO LH ZBH

Trina Mukherjee

Medical Products Industry's Near-Term Outlook Lacks Spark

AI & Robotics can drive the medical products industry amid the coronavirus-induced crisis.

ZBH SYK RMD PRGO MDT ISRG HRC BSX BAX ABT

Zacks Equity Research

Zimmer Biomet Adds New Features to mymobility with Apple Watch

Zimmer Biomet (ZBH) expands mymobility digital platform by leveraging Apple's ecosystem to enhance patients' post-operative care.

AAPL DGX HOLX ZBH

Zacks Equity Research

The Smart Future: Will Robotics Call the Shots Post Coronavirus?

Robots are assisting in surprising ways on the COVID frontline. With their pivotal role in battling the coronavirus, robotics revolution is swiftly gaining momentum and soon might be the new normal.

MSFT MDT DPZ SYK AMZN ZBH UBER

Zacks Equity Research

Zimmer (ZBH) Up 18.1% Since Last Earnings Report: Can It Continue?

Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

ZBH

Zacks Equity Research

Zimmer Biomet Faces Procedure Delays, Long-Term Potential Solid

Zimmer Biomet (ZBH) believes COVID-19 to continue to have a significant unfavorable impact on its sales in the near term.

OMI SRDX ZBH APHA

Zacks Equity Research

Zimmer Biomet (ZBH) Q1 Earnings Top, Revenues Miss Estimates

The spread of coronavirus results in deferral of elective procedures for Zimmer Biomet (ZBH) in Q1.

BIIB LLY ZBH APHA

Zacks Equity Research

Zimmer Biomet (ZBH) Beats Q1 Earnings Estimates

Zimmer (ZBH) delivered earnings and revenue surprises of 22.30% and -0.34%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

ZBH

Zacks Equity Research

How Hard Will Coronavirus Hit Zimmer Biomet (Zbh) Q1 Earnings?

Zimmer Biomet (ZBH) may have registered improved performances within its Hips and Knees arms due to the nature of the businesses.

HAE EXAS ZBH ACB

Zacks Equity Research

Here's Why You Should Add Zimmer Biomet to Your Portfolio Now

Investors continue to be optimistic about Zimmer Biomet (ZBH) on its strong segmental and international results in the fourth quarter of 2019.

MDT RMD HRC ZBH

Zacks Equity Research

Zimmer Biomet Grows on Strong Emerging Market, Innovation

Zimmer Biomet (ZBH) solidifies its foothold in the emerging markets on strong operational and sales performance.

MDT RMD HRC ZBH

Zacks Equity Research

ZBH or MDT: Which Is the Better Value Stock Right Now?

ZBH vs. MDT: Which Stock Is the Better Value Option?

ZBH MDT

Sreoshi Bera

Robotics & AI Make Inroads in HealthCare: Stocks to Benefit

Robotics and AI make rapid advancement in the field of healthcare. Here are five stocks that you can bet on.

MDT SYK NVDA PTC ZBH

Zacks Equity Research

Align Technology to Acquire exocad in Digital Dentistry Space

This acquisition is expected to boost Align Technology's (ALGN) portfolio of Invisalign and iTero digital solutions.

XRAY DHR ALGN ZBH

Zacks Equity Research

Why Is Zimmer (ZBH) Down 12.5% Since Last Earnings Report?

Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

ZBH

Trina Mukherjee

Medical Products Industry Outlook: Growth Prospects Bright

Growth prospects look bright for the Zacks Medical Products industry, courtesy of AI, Medical Mechatronics and Robotics and growing R&D expenditure.

ZBH SYK RMD PRGO MDT ISRG HRC BSX BAX ABT

Zacks Equity Research

Here's Why You Should Add Zimmer (ZBH) to Your Portfolio

Investors continue to be optimistic about Zimmer's (ZBH) potential on its strong segmental and international results for the fiscal fourth quarter.

RMD HRC LMAT ZBH